ghk-cu clinical trial news 2025 Facial Serum GHK-Cu Injectable - Team Wellcore

The evidence was based on experimental data only briefly described in the patent and included models of: gastric ulcers, heart damage, liver damage, pancreatic injury, kidney damage, experimental diabetes, fever, edema, rhinitis, bone fracture, burns, skin wounds, hypersensitivity reactions, pupil dilation, colon injury, tumour growth, radiation injury, red blood cell development, fertility and lactation, tooth damage, several types of central and peripheral nerve damage, and survival from infection with Trichinosis (i.e., tapeworms) as well as several viruses

ISO-tested by Vanguard Laboratory

Who Should Get the Injection

Plain-language research summary.

Fast UK dispatch, free delivery.

The Chicago-based Eden Scientific provides research-use-only peptides, bioregulators, reagents, and substrates